GMAB
NASDAQ HEALTHCAREGenmab AS
$29.03
$0.23 (+0.80%)
Live quote
52w: $21.00 – $35.43
Loading chart…
P/E Ratio1.92
P/B Ratio0.32
EV/EBITDA—
Debt/Equity—
ROE16.47%
ROIC—
Revenue Growth19.19%
Gross Margin—
Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark.
Own GMAB? Track it here.
Create a free account to add GMAB to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.